Cambium Networks (CMBM) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 revenue was $45.9 million, up 9% sequentially but down 23% year-over-year, driven by enterprise and PMP growth, with declines in PTP and PMP segments partially offset by enterprise gains.
Adjusted gross margin improved quarter-over-quarter to 33.5% non-GAAP and 31.4% GAAP, though impacted by $7 million in inventory charges.
Operating loss narrowed sequentially, with net loss at $9.1 million GAAP and $7.1 million non-GAAP; adjusted EBITDA loss improved to $6.7 million.
Cash balance increased to $42.6 million as of June 30, 2024, supported by positive operating cash flow and credit facility drawdowns.
Management is focused on cost controls, operating efficiency, and aligning cost structure with revenue amid macroeconomic and industry headwinds.
Financial highlights
Q2 2024 non-GAAP gross margin was 33.5%, up from 22.7% in Q1 2024, but down from 49.1% in Q2 2023.
Q2 2024 non-GAAP net loss was $7.1 million ($0.25 per diluted share), improved from $12.7 million loss in Q1.
Adjusted EBITDA loss was $6.7 million, better than $15.5 million loss in Q1.
Cash provided by operating activities was $2.4 million, the first positive result in six quarters.
Free cash flow was negative $1.8 million; cash balance stood at $42.6 million as of June 30.
Outlook and guidance
Q3 2024 revenue expected between $43–$48 million; non-GAAP gross margin between 41.5%–43.5%.
Q3 non-GAAP net loss projected between $5.4–$3.8 million; adjusted EBITDA between -$4.4–$2.4 million.
Full year 2024 revenue guidance is $180–$190 million, with non-GAAP gross margin around 37%.
Full year non-GAAP net loss expected between $29.4–$24.6 million; adjusted EBITDA margin between -16.2% and -12%.
Management expects continued sequential improvement, especially in enterprise and PMP segments.
Latest events from Cambium Networks
- Virtual meeting to vote on directors, auditor, compensation, and reverse share split; board supports all.CMBM
Proxy filing12 May 2026 - Q3 2025 revenue fell 3.7% year-over-year, with a net loss of $8.5 million and ongoing debt defaults.CMBM
Q3 202530 Apr 2026 - Revenue fell 12.9% year-over-year as liquidity and covenant risks threaten ongoing operations.CMBM
Q2 202530 Apr 2026 - 2024 saw a 21.8% revenue drop, major impairments, and severe liquidity and going concern risks.CMBM
Q4 20247 Apr 2026 - Revenue and margins improved, but debt covenant breaches threaten financial stability.CMBM
Q3 202415 Jan 2026